| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.36 | 0.05 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |